These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1010 related articles for article (PubMed ID: 32510146)
1. Identification of metastasis and prognosis-associated genes for serous ovarian cancer. Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146 [TBL] [Abstract][Full Text] [Related]
2. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis. Wu M; Sun Y; Wu J; Liu G Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586 [TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer. Moran-Jones K; Gloss BS; Murali R; Chang DK; Colvin EK; Jones MD; Yuen S; Howell VM; Brown LM; Wong CW; Spong SM; Scarlett CJ; Hacker NF; Ghosh S; Mok SC; Birrer MJ; Samimi G Oncotarget; 2015 Dec; 6(42):44551-62. PubMed ID: 26575166 [TBL] [Abstract][Full Text] [Related]
5. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer. Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492 [TBL] [Abstract][Full Text] [Related]
6. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis. Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638 [TBL] [Abstract][Full Text] [Related]
7. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis. Li Y; Li L J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725 [TBL] [Abstract][Full Text] [Related]
8. A Five-Gene Expression Signature Predicts Ovarian Cancer Metastasis. Gu Y; Zhang S Crit Rev Eukaryot Gene Expr; 2021; 31(5):41-50. PubMed ID: 34591389 [TBL] [Abstract][Full Text] [Related]
9. A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer. Zong S; Xu PP; Xu YH; Guo Y J Ovarian Res; 2022 Aug; 15(1):90. PubMed ID: 35915456 [TBL] [Abstract][Full Text] [Related]
10. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis. Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978 [TBL] [Abstract][Full Text] [Related]
11. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins. Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227 [TBL] [Abstract][Full Text] [Related]
12. Exploring prognostic genes in ovarian cancer stage-related coexpression network modules. Yang L; Jing J; Sun L; Yue Y Medicine (Baltimore); 2018 Aug; 97(34):e11895. PubMed ID: 30142790 [TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses. Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144 [TBL] [Abstract][Full Text] [Related]
14. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis. Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424 [TBL] [Abstract][Full Text] [Related]
15. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay. Zhang L; Sun L; Zhang B; Chen L Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312 [TBL] [Abstract][Full Text] [Related]
16. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696 [TBL] [Abstract][Full Text] [Related]
17. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578 [TBL] [Abstract][Full Text] [Related]
18. Identification of prevention marker associated with DNA replication in ovarian cancer: Expression of MCM2 protein and bioinformatics analysis. Lv H; Du Y; Xin P; Zhong Y; Liu Z; Jing Y Int J Biol Macromol; 2024 Nov; 279(Pt 1):135079. PubMed ID: 39187104 [TBL] [Abstract][Full Text] [Related]
19. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma. Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213 [TBL] [Abstract][Full Text] [Related]
20. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments. Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]